The slip
PARKINSON RECEIPTno. 12596
28 Oct 2026, 02:58 UTColigodendrocytes, braak
predictionDLC1 in oligodendrocytes tracks Braak Lewy-body stage
registered8be9b1b888f8c8db
discovery+0.21 p=0.586 n=9
replication+0.62 p=0.073 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.21, p 0.586)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTbf9d6242ed5d648e03b20841…
follows fd84dad8ed40…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 12596: DLC1 in oligodendrocytes, braak
- power
- full sample +0.28 (p 0.261, n 18), 95% CI -0.22 to +0.66. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.25 (p 0.323, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.13 (p 0.609, n 18). could be the mix.
- skeptic
- leave-one-out range +0.17 to +0.46, sign flips 0; without severely affected donors +0.28 (p 0.261, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DLC1 in oligodendrocytes.
case closed: nothing better to follow up.